We note that TMEM217 is highly induced in leukemia samples assayed with GeneChips and RNA sequencing (Figs 5C and S3C) and patients diagnosed with acute myeloid leukemia (LAML) show a decreased survival rate when the gene is highly expressed (Fig. S4C). This evidence concerns the gene TMEM217 and leukemia.